Abstract
Calmodulin (CaM) is a ubiquitous Ca2+-sensor protein that plays an important role in regulating a large number of Ca2+ channels, including the inositol 1,4,5-trisphosphate receptor (IP3R). CaM binds to the IP3R at Ca2+-dependent as well as at Ca2+-independent interaction sites. In this study, we have investigated the Ca2+-independent CaM-binding site for its role in the regulation of the Ca2+-dependent bell-shaped activation curve of the IP3R. Suramin, a polysulfonated napthylurea, displaced CaM in both the presence and the absence of Ca2+. Suramin competed with CaM for binding to different peptides representing the previously identified CaM-binding sites on IP3R1. By interacting with the N-terminal Ca2+-independent CaM-binding site, suramin mimicked the functional effect of CaM and induced an allosteric but competitive inhibition of IP3 binding. Therefore, suramin also potently inhibited IP3-induced Ca2+ release (IICR) from permeabilized cells predominantly expressing IP3R1 (L15 fibroblasts) or IP3R3 (Lvec fibroblasts), even though the IP3R3 does not contain Ca2+-dependent CaM-binding sites. Furthermore, we have found that CaM1234, a CaM mutated in its four EF hands, inhibited IICR in a Ca2+-dependent way with the same potency as CaM. We conclude that CaM inhibits IICR via the N-terminal binding site. The inhibition requires Ca2+ but CaM itself is not the Ca2+ sensor for the inhibition of the IP3R.
- Received February 25, 2004.
- Accepted April 18, 2004.
- The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|